Executive Directors
Mr. XU Jun (徐軍), age 40, was appointed as an executive Director on 8 January 2010 and is the chief executive officer of our Company. Mr. Xu is responsible for the overall business strategy and corporate development of our Group. Mr. Xu has been responsible for the overall management of our Group since the incorporation of our Company. Mr. Xu has over 17 years of experience in the pharmaceutical industry through his working experience in Shenzhen Sanjiu and its subsidiaries (the "Shenzhen Sanjiu Group") since 1992. Prior to joining our Group, Mr. Xu held various managerial positions, including sales manager, head of sales department and deputy general manager in a company within the Shenzhen Sanjiu Group from 1992 to 2001. Mr. Xu obtained his bachelor of science degree in Economics from the Renmin University of China (中國人民大學) in 1992 and executive master degree in business administration from the China Europe International Business School in 2003 .Mr. Xu has entered into a service contract with our Company for a term of three years commencing on 9 April 2010.
Mr. LIU Xiao Dong (劉曉東), age 40, was appointed as an executive Director on 8 January 2010 and is the senior vice president of our Company in charge of operations management of the Group. Mr. Liu joined our Group at the end of 2001. Prior to joining our Group, Mr. Liu had been deputy head of the finance department and director of the auditing office of a company within the Shenzhen Sanjiu Group from 1992 to 2001. He has over 17 years of experience in the pharmaceutical industry through his working experience in Shenzhen Sanjiu Group since 1992. Mr. Liu obtained his bachelor’s degree in economics from Wuhan University (武漢大學) in 1992.Mr. Liu has entered into a service contract with our Company for a term of three years commencing on 9 April 2010.
Non-executive Directors
Mr. Stephen Burnau HUNT, age 71, was appointed as a non-executive Director and chairman on 9 April 2010. Mr. Hunt is the deputy chairman and an executive director of CIH. He was formerly managing director of Aliant Capital, an investment company in Hong Kong. Mr. Hunt, a US citizen, spent 24 years with Bank of America in international management and lending positions. He was senior vice-president and area general manager for Bank of America located in Hong Kong. Mr. Hunt was president of the American Chamber of Commerce in Hong Kong in 1989. In 1990, Mr. Hunt was appointed to the Hong Kong Government’s International Business Committee, and from 1989 to 1991 was a member of the Hong Kong Government’s Advisory Committee on Free Trade. Mr. Hunt is currently a trustee of the American Chamber of Commerce’s Charitable Foundation. Mr.Hunt is also a member of the Main Board and GEM Listing Committee of the Stock Exchange. Mr. Hunt obtained a bachelor of arts degree from Duke University in 1961 and a master’s degree in international affairs from Columbia University in 1963. Mr. Hunt has entered into a letter of appointment with our Company for a term of three years commencing on 9 April 2010.
Mr. LEE Jin Yi (李晉頤), age 53, was appointed as a non-executive Director on 9 April 2010. Mr. Lee joined the CIH Group in January 2010 and is the Chief Executive Officer of CIH. Mr. Lee has extensive experience in the banking industry and held various senior management positions with major financial institutions over the past 20 years. Mr. Lee has been a director of Xiamen City Commercial Bank. Prior to joining the CIH Group, Mr. Lee was the managing director and chief executive officer of Fubon Bank (Hong Kong) Limited for five and half years and a director of Fubon Financial Holding Company Limited. Prior to that, Mr. Lee was the managing director and China senior country officer of J.P. Morgan Chase & Co. and chairman of the Hong Kong Management Committee of J.P. Morgan Chase & Co. Mr. Lee obtained a master’s degree in business administration from Harvard University in 1984. Mr. Lee has entered into a letter of appointment with our Company for a term of three years commencing on 9 April 2010.
Mr. TANG Jun (湯軍), age 51, will be appointed as a non-executive Director on 9 April 2010. Mr. Tang joined the CIH Group in 1994 and has been working in the business development department, responsible for exploring investment opportunities in the pharmaceutical industries for our Group. Currently Mr. Tang is the Vice-president and head of business development of the CIH Group. Mr. Tang is also acting as chairman for Ningbo Liwah,Shenzhen Lansen and Ningbo Lansen, and a director of Xian Haotian. Mr. Tang obtained a bachelor of philosophy degree from Hangzhou University in 1982 (杭州大學), a master of philosophy degree from Beijing Normal University (北京師範大學) in 1986 and a licentiate degree in Law from Lapland University, Finland in 1993. Mr. Tang has entered into a letter of appointment with our Company for a term of three years commencing on 9 April 2010.
Ms. TAO Fang Fang (陶芳芳), age 40, was appointed as a non-executive Director on 8 January 2010. Ms. Tao joined the CIH Group in 2007 and is also acting as a director of Xian Haotian. Ms. Tao became a professional accountant and a registered accountant in 1996 and 1998 respectively. Before being promoted to the position of director of finance department of a leading pharmaceutical group in China, Ms. Tao worked as financial controller for a manufacturing company and financial manager for a marketing and sales company under the control of that group. Ms. Tao graduated from the department of accounting of Shanghai University of Finance and Economics (上海財經大學) in 1992.Ms.Tao has entered into a letter of appointment with our Company for a term of three years commencing on 9 April 2010.
Ms. YIP Pui Ling, Rebecca (葉佩玲), age 52, was appointed as a non-executive Director on 10 September 2009 and is also the company secretary, Vice-president and head of asset management of the CIH Group responsible for the management of the operations of the CIH Group’s invested projects and is also acting as Chairman of Xian Haotian and its subsidiaries. Ms. Yip is a fellow of HKICPA since 1994, a fellow of ACCA since 1991,and an associate of ICAEW since 2008. Ms. Yip is also an associate of The Institute of Chartered Secretaries and Administrators since 1988 and The Hong Kong Institute of Company Secretaries since 1994. Prior to joining the CIH Group in February 1994, Ms. Yip worked for KPMG as an auditor and tax consultant for seven years. Ms. Yip graduated from Lingnan College where she obtained a Diploma in Business Administration and Accounting in 1981 and a Honours Diploma in Accounting in 1983. Ms. Yip has entered into a letter of appointment with our Company for a term of three years commencing on 9 April 2010.
Independent Non-executive Directors
Mr. CHAN Kee Huen, Michael (陳記煊), age59, was appointed as an independent nonexecutive Director on 9 April 2010. Mr. Chan has over 30 years of external audit, IT audit,training, accounting and finance, company secretarial and corporate administration, MIS management, internal audit, information security, risk management and compliance experience. Mr Chan is a fellow of the HKICPA and The Chartered Association of Certified Accountants, a fellow and specialist in Information Technology of CPA Australia and an associate of The ICAEW. Mr Chan is also associate or member of the following professional bodies: The Hong Kong Computer Society, Hong Kong Securities Institute,the Chartered Institute of Arbitrators and the Life Management Institute. He is also a Certified Information Systems Auditor with the Information Systems Audit and Control Association and a Fellow of the Hong Kong Institute of Directors. Mr. Chan is the chief executive of C&C Advisory Services Limited and an adjunct professor in the School of Accounting and Finance of the Hong Kong Polytechnic University. Mr. Chan has worked at CMG Life Assurance Limited (formerly Jardine CMG Life Assurance Limited) from 1991 to 1996 and his last position was general manager, compliance. He was the head of internal audit of Dao Heng Bank/Guoco Group Limited from 1996 to 2000, the head of compliance in Greater China, managing director of DBS Bank (Hong Kong) Limited from 2001 to 2003, the group financial controller of Lam Soon (Hong Kong) Limited from 2004 to 2005, the director of Quality Assurance of HKICPA in 2006 and the head of group compliance of Ping An Insurance (Group) Company of China, Limited from December 2006 to April 2009. Mr. Chan graduated with a higher diploma in accountancy from Hong Kong Polytechnic in 1976. Mr. Chan has entered into a letter of appointment with the Company for a term of three years commencing on 9 April 2010.
Mr. Tang Chiu Ping, Raymond (鄧昭平), age 62, was appointed as an independent nonexecutive Director on 9 April 2010. Mr. Tang has been in the executive search field since 1985 when he joined the Hong Kong office of Russell Reynolds Associates. Mr Tang was formerly Chairman, Greater China at Russell Reynolds Associates until late 2008 when he retired from the industry. Mr. Tang was educated in the United States at Tufts University in Boston, Massachusetts where he obtained a bachelor of Arts degree in 1972; and he graduated with a master’s degree in public health from the Yale University School of Medicine in New Haven, Connecticut in 1975. He has served as a member of nongovernmental organizations such as the Hong Kong Council of Academic Accreditation & Vocational Qualifications. Mr. Tang has entered into a letter of appointment with the Company for a term of three years commencing on 9 April 2010.
Mr. Fritz Heinrich Horlacher, age 62, has over 30 years’ experience in the pharmaceutical industry. Mr. Horlacher started his pharmaceutical career with Roche Australia in 1974. Mr. Horlacher worked at Zuellig Pharma Asia Pacific (“Zuellig Pharma”) from 1981 to 2008. Mr. Horlacher was the chief executive officer of Zuellig Pharma from 1995 to 2008 and was responsible for its operations servicing more than 125 international research-based pharmaceutical manufacturers in the Asia Pacific region. Mr. Horlacher retired as chief executive of Zuellig Pharma in 2008. Mr. Horlacher is currently a non-executive director of Pharma Industries Holdings Limited which has operations in the Philippines and Thailand. He was an alternate director of Invida Group Pte Ltd for two years from 2005 to 2007. Mr. Horlacher was a non-executive director of Australian Pharmaceutical Industries Limited (a company listed on the Australian Securities Exchange) for two years from 2002 to 2004. Mr. Horlacher was the Asia representative on the Board of Directors of the International Federation of Pharmaceutical Wholesalers from 2002 to 2008. Mr. Horlacher graduated in 1969 from Montana Institute in Switzerland and from Union College in South Africa in 1972. The appointment of Mr. Horlacher is for a term of three years commencing from 10 February 2011.